These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5686327)

  • 21. [Use of TPN-12 in 25 chronic schizophrenic patients].
    Medina Gil C; Samaniego Rodríguez C
    Arch Neurobiol (Madr); 1969; 32(4):559-73. PubMed ID: 5380328
    [No Abstract]   [Full Text] [Related]  

  • 22. Acute phenothiazine dystonia.
    Gillis A
    Lancet; 1969 Dec; 2(7633):1299-300. PubMed ID: 4188001
    [No Abstract]   [Full Text] [Related]  

  • 23. [ECG picture in the course of treatment of schizophrenia with phenothiazine derivatives].
    Welbel L; Zalewski K
    Psychiatr Pol; 1971; 5(1):49-54. PubMed ID: 5551991
    [No Abstract]   [Full Text] [Related]  

  • 24. The EEG's of chronic schizophrenic patients in hospital and in the community.
    Tarrier N; Cooke EC; Lader MH
    Electroencephalogr Clin Neurophysiol; 1978 May; 44(5):669-73. PubMed ID: 77771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical determination of unique effect of potentiation of phenothiazine medication by nylidrin hydrochloride.
    Chu J; Doering MF; Fogel EJ
    Int J Neuropsychiatry; 1966 Feb; 2(1):53-9. PubMed ID: 5907814
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of chronic schizophrenic psychoses with a thioridazine derivative].
    Glatzel J
    Med Welt; 1972 Jan; 23(2):62-4. PubMed ID: 5059991
    [No Abstract]   [Full Text] [Related]  

  • 27. Excessive mortality in schizophrenic patients on chronic phenothiazines treatment.
    Matsuki A; Oyama T; Izai S; Zsigmond EK
    Agressologie; 1972; 13(6):407-18. PubMed ID: 4652242
    [No Abstract]   [Full Text] [Related]  

  • 28. Life history and symptoms in schizophrenia. Severity at hospitalization and response to phenothiazines.
    Schooler NR; Boothe H; Goldberg SC
    Arch Gen Psychiatry; 1971 Aug; 25(2):138-47. PubMed ID: 5106102
    [No Abstract]   [Full Text] [Related]  

  • 29. [A comparison of the EEG activation with fatigue or sleep, pentothal and chlorpromazine in epileptic patients].
    Barańska-Gieruszczak M; Zieliński JJ
    Neurol Neurochir Pol; 1972; 6(5):771-5. PubMed ID: 4638171
    [No Abstract]   [Full Text] [Related]  

  • 30. PENTOTHAL INDUCED CHANGES IN EEG AS A PROGNOSTIC INDEX IN DRUGS THERAPY OF PSYCHOTIC PATIENTS.
    ITIL TM
    Am J Psychiatry; 1965 Apr; 121():996-1002. PubMed ID: 14272999
    [No Abstract]   [Full Text] [Related]  

  • 31. Correlations between different EEG patterns and serum concentrations during Phenothiazine therapy.
    Helmchen H; Kanowski S
    Electroencephalogr Clin Neurophysiol; 1969 Sep; 27(7):687. PubMed ID: 4187356
    [No Abstract]   [Full Text] [Related]  

  • 32. The hospitalization proneness scale as a predictor of response to phenothiazine treatment.
    Rosen B; Engelhardt DM; Freedman N; Margolis R
    J Nerv Ment Dis; 1968 Jun; 146(6):476-80. PubMed ID: 5677025
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of hydroxyzine on phenothiazine therapy.
    Ross EK; Priest RG
    Dis Nerv Syst; 1970 Jun; 31(6):412-4. PubMed ID: 4393988
    [No Abstract]   [Full Text] [Related]  

  • 34. Combined phenothiazine, chlordiazepoxide and primidone therapy for uncontrolled psychotic patients.
    Monroe RR; Wise SP
    Am J Psychiatry; 1965 Dec; 122(6):694-8. PubMed ID: 5320821
    [No Abstract]   [Full Text] [Related]  

  • 35. Phenothiazine effects in good premorbid schizophrenics divided into paranoid-nonparanoid status.
    Judd LL; Goldstein MJ; Rodnick EH; Jackson NL
    Arch Gen Psychiatry; 1973 Aug; 29(2):207-21. PubMed ID: 4582360
    [No Abstract]   [Full Text] [Related]  

  • 36. Piperacetazine (Quide): a controlled evaluation of the elixir in chronic schizophrenic patients.
    Gallant DM; Bishop MP
    Curr Ther Res Clin Exp; 1970 Jun; 12(6):387-9. PubMed ID: 4987346
    [No Abstract]   [Full Text] [Related]  

  • 37. Time-series analysis of the effects of barbiturates on the electroencephalograms of psychotic and nonpsychotic men.
    Murphree HB; Pfeiffer CC; Goldstein L; Sugerman AA; Jenney EH
    Clin Pharmacol Ther; 1967; 8(6):830-40. PubMed ID: 6059288
    [No Abstract]   [Full Text] [Related]  

  • 38. Piperacetazine in ambulatory chronic schizophrenic patients.
    Rada RT; Donlon PT
    Curr Ther Res Clin Exp; 1974 Feb; 16(2):124-9. PubMed ID: 4156665
    [No Abstract]   [Full Text] [Related]  

  • 39. Withdrawal of ataractic medication in schizophrenic patients.
    Garfield SL; Gershon S; Sletten I; Neubauer H; Ferrel E
    Dis Nerv Syst; 1966 May; 27(5):321-5. PubMed ID: 5327466
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical experimentation with a new phenothiazine derivative, propericiazine (Neuleptil), on a group of patients affected by schizophrenia and deliriant psychoses].
    Ghedini G
    Minerva Med; 1967 Jan; 58(6):131-41. PubMed ID: 4381122
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.